Literature DB >> 25349313

Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial.

Claudia Marhuenda1, Concepció Barceló2, Inmaculada Fuentes3, Gabriela Guillén2, Indalecio Cano4, María López4, Francisco Hernández5, Eduardo G Pérez-Yarza6, José A Matute7, María A García-Casillas7, Víctor Alvarez8, Antonio Moreno-Galdó9.   

Abstract

BACKGROUND AND
OBJECTIVE: Parapneumonic empyema (PPE) is a frequent complication of acute bacterial pneumonia in children. There is limited evidence regarding the optimal treatment of this condition. The aim of this study was to compare the efficacy of drainage plus urokinase versus video-assisted thoracoscopic surgery in the treatment of PPE in childhood.
METHODS: This prospective, randomized, multicenter clinical trial enrolled patients aged <15 years and hospitalized with septated PPE. Study patients were randomized to receive urokinase or thoracoscopy. The main outcome variable was the length of hospital stay after treatment. The secondary outcomes were total length of hospital stay, number of days with the chest drain, number of days with fever, and treatment failures. The trial was approved by the ethics committees of all the participating hospitals.
RESULTS: A total of 103 patients were randomized to treatment and analyzed; 53 were treated with thoracoscopy and 50 with urokinase. There were no differences in demographic characteristics or in the main baseline characteristics between the 2 groups. No statistically significant differences were found between thoracoscopy and urokinase in the median postoperative stay (10 vs 9 days), median hospital stay (14 vs 13 days), or days febrile after treatment (4 vs 6 days). A second intervention was required in 15% of children in the thoracoscopy group versus 10% in the urokinase group (P = .47).
CONCLUSIONS: Drainage plus urokinase instillation is as effective as video-assisted thoracoscopic surgery as first-line treatment of septated PPE in children.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  VATS; children; empyema; fibrinolytics; parapneumonic effusions; randomized clinical trial; urokinase; video-assisted thoracoscopic surgery

Mesh:

Substances:

Year:  2014        PMID: 25349313     DOI: 10.1542/peds.2013-3935

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Establishing Equipoise: National Survey of the Treatment of Pediatric Para-Pneumonic Effusion and Empyema.

Authors:  Morgan K Richards; Jarod P Mcateer; Todd C Edwards; Lucas R Hoffman; Matthew P Kronman; Dennis W Shaw; Adam B Goldin
Journal:  Surg Infect (Larchmt)       Date:  2016-11-29       Impact factor: 2.150

2.  The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

Authors:  Andrey A Komissarov; Galina Florova; Ali O Azghani; Ann Buchanan; William M Bradley; Chris Schaefer; Kathleen Koenig; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

Review 3.  Surgical versus non-surgical management for pleural empyema.

Authors:  Mark D Redden; Tze Yang Chin; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-17

4.  Efficacy of video-assisted thoracoscopic surgery versus intrapleural streptokinase for treatment of parapneumonic empyema with multiloculation and septation.

Authors:  Reza Ershadi; Matin Vahedi; Shahab Rafieian
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-06-29

5.  Making the transition from video-assisted thoracoscopic surgery to chest tube with fibrinolytics for empyema in children: Any change in outcomes?

Authors:  Michael H Livingston; Sara Colozza; Kelly N Vogt; Neil Merritt; Andreana Bütter
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

6.  Initial treatment of septated parapneumonic empyema with drainage plus fibrinolytic agents is equally effective as video-assisted thoracoscopic surgery, and is suitable as first-line therapy.

Authors:  Chiyoe Shirota; Hiroo Uchida
Journal:  Transl Pediatr       Date:  2015-01

7.  Role of Intrapleural Urokinase in Empyema Thoracis.

Authors:  Devki Nandan; Sheetal Agarwal; Neha Bidhuri; Kavita Shrivastava; Pamali Nanda; Sandhya Lata
Journal:  Indian J Pediatr       Date:  2019-10-18       Impact factor: 1.967

8.  Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.

Authors:  Michael H Livingston; Sanjay Mahant; Felix Ratjen; Bairbre L Connolly; Kevin Thorpe; Muhammad Mamdani; Ian Maclusky; Sophie Laberge; Lucy Giglia; J Mark Walton; Connie L Yang; Ashley Roberts; Anna C Shawyer; Mary Brindle; Simon J Parsons; Cristina A Stoian; Eyal Cohen
Journal:  Trials       Date:  2017-06-24       Impact factor: 2.279

9.  Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study.

Authors:  Florian J Segerer; Karin Seeger; Anna Maier; Christine Hagemann; Christoph Schoen; Mark van der Linden; Andrea Streng; Markus A Rose; Johannes G Liese
Journal:  Pediatr Pulmonol       Date:  2016-09-20

10.  Real-time ultrasound-guided pigtail catheter chest drain for complicated parapneumonic effusion and empyema in children - 16-year, single-centre experience of radiologically placed drains.

Authors:  Megan R Lewis; Thomas A Micic; Iolo J M Doull; Alison Evans
Journal:  Pediatr Radiol       Date:  2018-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.